tiprankstipranks
Keymed Biosciences Licenses CM355 to Prolium for Global Development
PremiumCompany AnnouncementsKeymed Biosciences Licenses CM355 to Prolium for Global Development
5M ago
Keymed Biosciences Secures Licensing Deal for CM313
Premium
Company Announcements
Keymed Biosciences Secures Licensing Deal for CM313
6M ago
Keymed Biosciences Gains NMPA Approval for Stapokibart
Premium
Company Announcements
Keymed Biosciences Gains NMPA Approval for Stapokibart
6M ago
Keymed Biosciences Faces Steep Revenue Decline
PremiumCompany AnnouncementsKeymed Biosciences Faces Steep Revenue Decline
10M ago
Keymed Biosciences Schedules Crucial Financial Meeting
Premium
Company Announcements
Keymed Biosciences Schedules Crucial Financial Meeting
11M ago
Keymed Biosciences Strikes Global Licensing Deal
Premium
Company Announcements
Keymed Biosciences Strikes Global Licensing Deal
12M ago
Keymed Reports Promising Cancer Drug Results
PremiumCompany AnnouncementsKeymed Reports Promising Cancer Drug Results
1y ago
Keymed Biosciences’ Stapokibart Gains Priority Review
Premium
Company Announcements
Keymed Biosciences’ Stapokibart Gains Priority Review
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100